Adaptimmune Therapeutics
ADAP
#9421
Rank
A$96.31 M
Marketcap
$0.37
Share price
-12.60%
Change (1 day)
-81.91%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Cash on Hand

Cash on Hand as of December 2024 : A$0.25 Billion

According to Adaptimmune Therapeutics's latest financial reports the company has A$0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Adaptimmune Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.21 B-28.27%
2022-12-31A$0.30 B-41.02%
2021-12-31A$0.50 B6.45%
2020-12-31A$0.47 B274.43%
2019-12-31A$0.12 B-56.08%
2018-12-31A$0.29 B9.16%
2017-12-31A$0.26 B5.96%
2016-12-31A$0.25 B
2015-06-30A$0.37 B580.61%
2014-06-30A$54.44 M19983.36%
2013-06-30A$0.27 M-90.82%
2012-06-30A$2.95 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.54 B 508.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$67.32 M-73.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.61 B 142.42%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$1.85 B 633.01%๐Ÿ‡บ๐Ÿ‡ธ USA